Cancer prevention research 2009; 14(3): 265-273
Published online September 30, 2009
© Korean Society of Cancer Prevention
Yun Kyung Hong1, Yu Na Oh2, Sook Kyung Hyun2, Hee Jung Yun3, Hye Jin Hwang2,4, Eun Woo Lee1,2, Byung Woo Kim1,2,3 and Hyun Ju Kwon1,2,3
We report here the widdrol, an odorous compound extracted from Juniperus chinensis, induced cell cycle arrest in human lung carcinoma A549 cells. We found the widdrol significantly induced cell-cycle arrest in G1 phase. To investigate the possible mechanisms, G1-related proteins were assayed by western blot analysis. Widdrol treatment resulted in the up-regulation of tumor suppressor p53 and cyclin-dependent kinase (CDK) inhibitor p21. In contrast, the expressions of cyclin-dependent kinase (CDK2), cyclin E, retinoblastoma protein (pRB) and proliferating cell nuclear antigen (PCNA) levels were markedly decreased in the concentration-dependent manner. Moreover, the minichromosome maintenance (MCM) proteins, highly expressed in cancer cells, were significantly down-regulated in A549 cells treated with widdrol. Overall, these observations suggest widdrol induces antiproliferation and arrest G1 phase in A549 cells, possibly mediated by the inhibition of the MCM protein expression. Consequently, widdrol is a potential candidate for the anticancer drug development. (Cancer Prev Res 14, 265-273, 2009)
Keywords: Widdrol, MCM protein, A549 cells, G1 arrest, CDK inhibitor
Soojung Jin, Jung-ha Park, Hee Jung Yun, You Na Oh, Seunghye Oh, Yung Hyun Choi, Byung Woo Kim, Hyun Ju Kwon
J Cancer Prev 2022; 27(4): 221-228 https://doi.org/10.15430/JCP.2022.27.4.221Sin-Yung Bae, Hae-Lim Lee, Kwang-Hyeon Kim, Chang-Hee Han1,
Young-Man Kim2, Byung-Woo Kim and Hyun-Ju Kwon
Hyork Kwon, Jae Im Kwon, Hyun Seop Eom, Yung Hyun Choi and Gyoo Yong Chi
Cancer prevention research 2007; 12(1): 58-66